LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.01 | 27.76 | 2976 | 7000 | 0.4251 | 0.7967 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.01 | 27.76 | 4482 | 7000 | 0.6403 | 0.8913 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.01 | 27.76 | 98 | 7000 | 0.0140 | 0.1713 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.01 | 27.76 | 4118 | 7000 | 0.5883 | 0.8713 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 83.72 | 27.76 | 2871 | 7055 | 0.4069 | 0.7871 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 83.72 | 27.76 | 4598 | 7055 | 0.6517 | 0.8956 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 83.72 | 27.76 | 54 | 7055 | 0.0077 | 0.0869 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 83.72 | 27.76 | 4104 | 7055 | 0.5817 | 0.8689 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 85.42 | 27.76 | 2651 | 7025 | 0.3773 | 0.7702 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 85.42 | 27.76 | 4644 | 7025 | 0.6610 | 0.8989 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 85.42 | 27.76 | 50 | 7025 | 0.0071 | 0.0765 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 85.42 | 27.76 | 4055 | 7025 | 0.5772 | 0.8670 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 87.13 | 27.76 | 2360 | 6987 | 0.3377 | 0.7455 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 87.13 | 27.76 | 4723 | 6987 | 0.6759 | 0.9041 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 87.13 | 27.76 | 46 | 6987 | 0.0066 | 0.0654 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 87.13 | 27.76 | 4022 | 6987 | 0.5756 | 0.8662 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 88.84 | 27.76 | 1788 | 6965 | 0.2567 | 0.6863 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 88.84 | 27.76 | 4764 | 6965 | 0.6840 | 0.9069 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 88.84 | 27.76 | 33 | 6965 | 0.0047 | 0.0219 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 88.84 | 27.76 | 3959 | 6965 | 0.5684 | 0.8632 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 90.55 | 27.76 | 1337 | 6928 | 0.1930 | 0.6267 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 90.55 | 27.76 | 4819 | 6928 | 0.6955 | 0.9109 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 90.55 | 27.76 | 32 | 6928 | 0.0046 | 0.0180 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 90.55 | 27.76 | 3864 | 6928 | 0.5577 | 0.8586 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 92.25 | 27.76 | 1106 | 6873 | 0.1609 | 0.5895 | MN20160318_Q01 | D10 |